172 related articles for article (PubMed ID: 33129605)
1. New Emerging Developments of Platelets in Transfusion Medicine.
Stolla M; Kapur R; Semple JW
Transfus Med Rev; 2020 Oct; 34(4):207-208. PubMed ID: 33129605
[No Abstract] [Full Text] [Related]
2. Clarify the negatives of the MIRASOL noninferiority trial.
Strauss RG
Transfusion; 2011 Jun; 51(6):1361-2; author reply 1362-4. PubMed ID: 21658043
[No Abstract] [Full Text] [Related]
3. Aging of platelets stored for transfusion.
Smethurst PA
Platelets; 2016 Sep; 27(6):526-34. PubMed ID: 27135140
[TBL] [Abstract][Full Text] [Related]
4. In reply to: "Is the SCID mouse model applicable to human acute lung injury?".
Goodrich RP
Transfusion; 2012 Nov; 52(11):2489-92; author reply 2492-4. PubMed ID: 23140431
[No Abstract] [Full Text] [Related]
5. Bacterial contamination in platelet concentrates.
Pietersz RN; Reesink HW; Panzer S; Oknaian S; Kuperman S; Gabriel C; Rapaille A; Lambermont M; Deneys V; Sondag D; Ramírez-Arcos S; Goldman M; Delage G; Bernier F; Germain M; Vuk T; Georgsen J; Morel P; Naegelen C; Bardiaux L; Cazenave JP; Dreier J; Vollmer T; Knabbe C; Seifried E; Hourfar K; Lin CK; Spreafico M; Raffaele L; Berzuini A; Prati D; Satake M; de Korte D; van der Meer PF; Kerkhoffs JL; Blanco L; Kjeldsen-Kragh J; Svard-Nilsson AM; McDonald CP; Symonds I; Moule R; Brailsford S; Yomtovian R; Jacobs MR
Vox Sang; 2014 Apr; 106(3):256-83. PubMed ID: 24654780
[No Abstract] [Full Text] [Related]
6. Platelet immunopathology and therapy: a Canadian Blood Services Research and Development Symposium.
Tinmouth AT; Semple E; Shehata N; Branch DR
Transfus Med Rev; 2006 Oct; 20(4):294-314. PubMed ID: 17008167
[No Abstract] [Full Text] [Related]
7. Transfusion medicine illustrated. Bacterial contamination of platelets: abnormal appearance prevents catastrophic events.
Thakral B; Dhawan HK; Das A; Saluja K; Sharma RR; Marwaha N; Sharma M
Transfusion; 2007 Nov; 47(11):1961-2. PubMed ID: 17958523
[No Abstract] [Full Text] [Related]
8. Non-Alloimmune Mechanisms of Thrombocytopenia and Refractoriness to Platelet Transfusion.
Belizaire R; Makar RS
Transfus Med Rev; 2020 Oct; 34(4):242-249. PubMed ID: 33129606
[TBL] [Abstract][Full Text] [Related]
9. Clinical effectiveness of leucoreduced, pooled donor platelet concentrates, stored in plasma or additive solution with and without pathogen reduction.
Kerkhoffs JL; van Putten WL; Novotny VM; Te Boekhorst PA; Schipperus MR; Zwaginga JJ; van Pampus LC; de Greef GE; Luten M; Huijgens PC; Brand A; van Rhenen DJ;
Br J Haematol; 2010 Jul; 150(2):209-17. PubMed ID: 20507310
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo evaluation of apheresis platelets stored for 5 days in 65% platelet additive solution/35% plasma.
Vassallo RR; Adamson JW; Gottschall JL; Snyder EL; Lee W; Houghton J; Elfath MD
Transfusion; 2010 Nov; 50(11):2376-85. PubMed ID: 20497516
[TBL] [Abstract][Full Text] [Related]
11. Physiology of cold-stored platelets.
Getz TM
Transfus Apher Sci; 2019 Feb; 58(1):12-15. PubMed ID: 30639086
[TBL] [Abstract][Full Text] [Related]
12. A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology.
Mirasol Clinical Evaluation Study Group
Transfusion; 2010 Nov; 50(11):2362-75. PubMed ID: 20492615
[TBL] [Abstract][Full Text] [Related]
13. Treating thrombocytopenia with pathogen-reduced platelets.
Sandler SG
Curr Hematol Rep; 2006 Mar; 5(1):53-4. PubMed ID: 16537046
[No Abstract] [Full Text] [Related]
14. The hemostatic efficacy of platelet components prepared with pathogen inactivation.
Corash L
Transfusion; 2011 Jun; 51(6):1355-6; author reply 1356-7. PubMed ID: 21658040
[No Abstract] [Full Text] [Related]
15. Benefits of lower neonatal platelet transfusion thresholds.
Hasan R; Saifee NH
Transfusion; 2021 Jun; 61(6):1672-1675. PubMed ID: 33786866
[TBL] [Abstract][Full Text] [Related]
16. A randomized study of buffy coat platelets in platelet additive solution stored 1-5 versus 6-7 days prior to prophylactic transfusion of allogeneic haematopoietic progenitor cell transplant recipients.
Diedrich B; Ringdén O; Watz E; Shanwell A
Vox Sang; 2009 Oct; 97(3):254-9. PubMed ID: 19508669
[TBL] [Abstract][Full Text] [Related]
17. EFFECT OF STORAGE UP TO 48 HOURS ON RESPONSE TO TRANSFUSIONS OF PLATELET RICH PLASMA.
LEVIN RH; FREIREICH EJ
Transfusion; 1964; 4():251-6. PubMed ID: 14177375
[No Abstract] [Full Text] [Related]
18. Pathogen reduction technologies: The pros and cons for platelet transfusion.
Magron A; Laugier J; Provost P; Boilard E
Platelets; 2018 Jan; 29(1):2-8. PubMed ID: 28523956
[TBL] [Abstract][Full Text] [Related]
19. The clot: platelet transfusion.
Chapman R
Rocky Mt Med J; 1977; 74(3):146-50. PubMed ID: 301288
[No Abstract] [Full Text] [Related]
20. Frozen Platelets-Development and Future Directions.
Kelly K; Cancelas JA; Szczepiorkowski ZM; Dumont DF; Rugg N; Dumont LJ
Transfus Med Rev; 2020 Oct; 34(4):286-293. PubMed ID: 33317698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
